Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Atomo Diagnostics Ltd. ( (AU:AT1) ) is now available.
Atomo Diagnostics Limited has issued 2,000,000 fully paid ordinary shares to a consultant as compensation for research services. This issuance was conducted without investor disclosure under specific provisions of the Corporations Act, and the company confirms compliance with relevant legal requirements. This move could enhance Atomo’s research capabilities, potentially impacting its market position and stakeholder interests.
More about Atomo Diagnostics Ltd.
Atomo is an Australian-headquartered medical device company that provides integrated rapid diagnostic test devices to the global market. Their patented devices improve testing procedures and reliability for point-of-care and at-home applications, with products targeting infectious diseases such as COVID-19 and HIV.
Average Trading Volume: 624,719
Technical Sentiment Signal: Sell
Current Market Cap: A$10.76M
Find detailed analytics on AT1 stock on TipRanks’ Stock Analysis page.